Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL LIFE SCIENCES BPO MARKET, BY SERVICE TYPE
6.1. Overview
6.2. Contract Research
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.1. Drug Discovery
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.2. Pre-Clinical and Clinical Trials
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.3. Pharmacovigilance
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.4. Clinical Data Management
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.5. Medical Writing
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.6. Regulatory Services
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.7. Clinical Monitoring
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.8. Protocol Development
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.2.9. Site Management
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.3. Contract Manufacturing
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
6.4. Contract Sales and Marketing
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7. GLOBAL LIFE SCIENCES BPO MARKET, BY APPLICATION
7.1. Overview
7.2. Medical Devices
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
7.3. Biopharma & Pharmaceuticals
Market Estimates & Forecast, by Region, 2022-2030
Market Estimates & Forecast, by Country, 2022-2030
8. GLOBAL LIFE SCIENCES BPO MARKET, BY REGION
8.1. Overview
8.2. Americas
8.2.1. North America
8.2.1.1. US
8.2.1.2. Canada
8.2.2. Latin America
8.3. Europe
8.3.1. Western Europe
8.3.1.1. Germany
8.3.1.2. France
8.3.1.3. Italy
8.3.1.4. Spain
8.3.1.5. UK
8.3.1.6. Rest of Western Europe
8.3.2. Eastern Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle East & Africa
8.5.1. Middle East
8.5.2. Africa
9. COMPANY LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Life Sciences BPO Market
9.5. Competitive Benchmarking
9.6. Leading Players in terms of Number of Developments in the Global Life Sciences BPO Market
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix & Market Ratio
9.8.1. Sales & Operating Income 2019
9.8.2. Major Players R&D Expenditure 2019
10. COMPANY PROFILES
10.1. Accenture plc
10.1.1. Company Overview
10.1.2. Product Type Overview
10.1.3. Financial Overview
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. Boehringer Ingelheim GmbH
10.2.1. Company Overview
10.2.2. Product Type Overview
10.2.3. Financial Overview
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. Charles River Laboratories
10.3.1. Company Overview
10.3.2. Product Type Overview
10.3.3. Financial Overview
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. Covance, Inc.
10.4.1. Company Overview
10.4.2. Product Type Overview
10.4.3. Financial Overview
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. Genpact Limited
10.5.1. Company Overview
10.5.2. Product Type Overview
10.5.3. Financial Overview
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. Catalent, Inc.
10.6.1. Company Overview
10.6.2. Product Type Overview
10.6.3. Financial Overview
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. Infosys Limited
10.7.1. Company Overview
10.7.2. Product Type Overview
10.7.3. Financial Overview
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. Health Decisions Inc.
10.8.1. Company Overview
10.8.2. Product Type Overview
10.8.3. Financial Overview
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Anthelio Healthcare Solutions
10.9.1. Company Overview
10.9.2. Product Type Overview
10.9.3. Financial Overview
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. Cognizant Technology Solutions
10.10.1. Company Overview
10.10.2. Product Type Overview
10.10.3. Financial Overview
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. ProMab Biotechnologies Inc.
10.11.1. Company Overview
10.11.2. Product Type Overview
10.11.3. Financial Overview
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Quintiles Translational Corporation
10.12.1. Company Overview
10.12.2. Product Type Overview
10.12.3. Financial Overview
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. Paraxel International Corporation
10.13.1. Company Overview
10.13.2. Product Type Overview
10.13.3. Financial Overview
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
10.14. Lonza Group
10.14.1. Company Overview
10.14.2. Product Type Overview
10.14.3. Financial Overview
10.14.4. Key Developments
10.14.5. SWOT Analysis
10.14.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL LIFE SCIENCES BPO MARKET SYNOPSIS, 2022-2030
TABLE 2 GLOBAL LIFE SCIENCES BPO MARKET ESTIMATES & FORECAST, 2022-2030 (USD BILLION)
TABLE 3 GLOBAL LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 4 GLOBAL LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 5 NORTH AMERICA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 6 NORTH AMERICA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 7 US: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 8 US: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 9 CANADA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 10 CANADA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 11 LATIN AMERICA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 12 LATIN AMERICA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 13 EUROPE: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 14 EUROPE: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 15 WESTERN EUROPE: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 16 WESTERN EUROPE: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 17 GERMANY: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 18 GERMANY: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 19 UK: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 20 UK: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 21 FRANCE: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 22 FRANCE: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 23 ITALY: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 24 ITALY: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 25 SPAIN: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 26 SPAIN: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 27 REST OF WESTERN EUROPE: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 28 REST OF WESTERN EUROPE: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 29 EASTERN EUROPE: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 30 EASTERN EUROPE: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 31 ASIA-PACIFIC: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 32 ASIA-PACIFIC: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 33 INDIA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 34 INDIA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 35 CHINA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 36 CHINA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 37 JAPAN: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 38 JAPAN: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 39 AUSTRALIA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 40 AUSTRALIA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 41 SOUTH KOREA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 42 SOUTH KOREA: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 43 REST OF ASIA-PACIFIC: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 44 REST OF ASIA-PACIFIC: LIFE SCIENCES BPO MARKET, BY APPLICATION, 2022-2030 (USD BILLION)
TABLE 45 MIDDLE EAST & AFRICA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 46 MIDDLE EAST & AFRICA: LIFE SCIENCES BPO MARKET, APPLICATION, 2022-2030 (USD BILLION)
TABLE 47 MIDDLE EAST: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 48 MIDDLE EAST: LIFE SCIENCES BPO MARKET, APPLICATION, 2022-2030 (USD BILLION)
TABLE 49 AFRICA: LIFE SCIENCES BPO MARKET, BY SERVICE TYPE, 2022-2030 (USD BILLION)
TABLE 50 AFRICA: LIFE SCIENCES BPO MARKET, APPLICATION, 2022-2030 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL LIFE SCIENCES BPO MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL LIFE SCIENCES BPO MARKET
FIGURE 4 GLOBAL LIFE SCIENCES BPO MARKET SHARE, BY SERVICE TYPE, 2019 (%)
FIGURE 5 GLOBAL LIFE SCIENCES BPO MARKET SHARE, BY APPLICATION, 2019 (%)
FIGURE 6 GLOBAL LIFE SCIENCES BPO MARKET SHARE, BY REGION, 2019 (%)
FIGURE 7 AMERICAS: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 8 NORTH AMERICA: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 9 EUROPE: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 10 WESTERN EUROPE: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 11 ASIA-PACIFIC: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 12 MIDDLE EAST & AFRICA: LIFE SCIENCES BPO MARKET SHARE BY REGION, 2019 (%)
FIGURE 13 GLOBAL LIFE SCIENCES BPO MARKET: COMPANY SHARE ANALYSIS, 2019 (%)
FIGURE 14 ACCENTURE PLC: KEY FINANCIALS
FIGURE 15 ACCENTURE PLC: SEGMENTAL REVENUE
FIGURE 16 ACCENTURE PLC: REGIONAL REVENUE
FIGURE 17 BOEHRINGER INGELHEIM GMBH.: KEY FINANCIALS
FIGURE 18 BOEHRINGER INGELHEIM GMBH.: SEGMENTAL REVENUE
FIGURE 19 BOEHRINGER INGELHEIM GMBH REGIONAL REVENUE
FIGURE 20 CHARLES RIVER LABORATORIES: KEY FINANCIALS
FIGURE 21 CHARLES RIVER LABORATORIES: SEGMENTAL REVENUE
FIGURE 22 CHARLES RIVER LABORATORIES: REGIONAL REVENUE
FIGURE 23 COVANCE, INC: KEY FINANCIALS
FIGURE 24 COVANCE, INC: SEGMENTAL REVENUE
FIGURE 25 COVANCE, INC: REGIONAL REVENUE
FIGURE 26 GENPACT LIMITED: KEY FINANCIALS
FIGURE 27 GENPACT LIMITED: SEGMENTAL REVENUE
FIGURE 28 GENPACT LIMITED: REGIONAL REVENUE
FIGURE 29 CATALENT, INC.: KEY FINANCIALS
FIGURE 30 CATALENT, INC.: SEGMENTAL REVENUE
FIGURE 31 CATALENT, INC.: REGIONAL REVENUE
FIGURE 32 INFOSYS LIMITED KEY FINANCIALS
FIGURE 33 INFOSYS LIMITED SEGMENTAL REVENUE
FIGURE 34 INFOSYS LIMITED.: REGIONAL REVENUE
FIGURE 35 HEALTHCARE DECISIONS, INC.: KEY FINANCIALS
FIGURE 36 HEALTHCARE DECISIONS, INC: SEGMENTAL REVENUE
FIGURE 37 HEALTHCARE DECISIONS, INC: REGIONAL REVENUE
FIGURE 38 ANTHELIO HEALTHCARE SOLUTIONS.: KEY FINANCIALS
FIGURE 39 ANTHELIO HEALTHCARE SOLUTIONS.: SEGMENTAL REVENUE
FIGURE 40 ANTHELIO HEALTHCARE SOLUTIONS.: REGIONAL REVENUE
FIGURE 41 COGNIZANT TECHNOLOGY SOLUTIONS.: KEY FINANCIALS
FIGURE 42 COGNIZANT TECHNOLOGY SOLUTIONS.: SEGMENTAL REVENUE
FIGURE 43 COGNIZANT TECHNOLOGY SOLUTIONS.: REGIONAL REVENUE
FIGURE 44 PROMAB BIOTECHNOLOGIES, INC.: KEY FINANCIALS
FIGURE 45 PROMAB BIOTECHNOLOGIES, INC: SEGMENTAL REVENUE
FIGURE 46 PROMAB BIOTECHNOLOGIES, INC: REGIONAL REVENUE
FIGURE 47 QUINTILES TRANSLATIONAL CORPORATION.: KEY FINANCIALS
FIGURE 48 QUINTILES TRANSLATIONAL CORPORATION.: SEGMENTAL REVENUE
FIGURE 49 QUINTILES TRANSLATIONAL CORPORATION: REGIONAL REVENUE
FIGURE 50 PARAXEL INTERNATIONAL CORPORATION.: KEY FINANCIALS
FIGURE 51 PARAXEL INTERNATIONAL CORPORATION.: SEGMENTAL REVENUE
FIGURE 52 PARAXEL INTERNATIONAL CORPORATION: REGIONAL REVENUE
FIGURE 53 LONZA GROUP: KEY FINANCIALS
FIGURE 54 LONZA GROUP: SEGMENTAL REVENUE
FIGURE 55 LONZA GROUP: REGIONAL REVENUE